CHRI curates and manages a searchable library of published scientific articles related to the health effects of cannabis.
Unfamiliar with a term?
Use the Search Fields to Find Information
This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.
Found 2431 Results
Page 18 of 244
The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases
Abstract The global incidence of respiratory diseases and complications is increasing. Therefore, new methods of treatment, as well as prevention, need to be investigated. A group of compounds that should…
The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review
Abstract Background: Around 2% of the population have intellectual disabilities. Over one-third people with intellectual disabilities (PwID) present with ‘challenging behaviour’, which nosologically and diagnostically is an abstract concept. Challenging behaviour…
The Place of Cannabinoids in the Treatment of Gynecological Pain
Abstract Cannabis sativa (L), a plant with an extensive history of medicinal usage across numerous cultures, has received increased attention over recent years for its therapeutic potential for gynecological disorders such…
The Pharmacological Case for Cannabigerol
ABSTRACT Medical cannabis and individual cannabinoids, such as D9- tetrahydrocannabinol (D9-THC) and cannabidiol (CBD), are receiving growing attention in both the media and the scientific literature. The Cannabis plant,…
The Pharmacological Basis of Cannabis Therapy for Epilepsy
Recently, cannabis has been suggested as a potential alternative therapy for refractory epilepsy, which affects 30% of epilepsy, both adults and children, who do not respond to current medications. There…
The Pharmacologic and Clinical Effects of Medical Cannabis
Cannabis, or marijuana, has been used for medicinal purposes for many years. Several types of cannabinoid medicines are available in the United States and Canada. Dronabinol (schedule III), nabilone (schedule…
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
Abstract Background Precise cannabis treatment dosing remains a major challenge, leading to physicians’ reluctance to prescribe medical cannabis. Objective To test the pharmacokinetics, analgesic effect, cognitive performance and safety effects…
The Pharmacogenetics of Cannabis in the Treatment of Chronic Pain
Abstract Background: The increase in the medical use of cannabis has revealed a number of beneficial effects, a variety of adverse side effects and great inter-individual variability. Association studies connecting…
The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man
Abstract The cannabinoid 1 (CB1) receptor regulates appetite and body weight; however, unwanted central side effects of both agonists (in wasting disorders) or antagonists (in obesity and diabetes) have limited…
The pattern of neurodegeneration in Huntington’s disease: a comparative study of cannabinoid, dopamine, adenosine and GABAa receptor alterations in the human basal ganglia in Huntington’s disease
In order to investigate the sequence and pattern of neurodegeneration in Huntington’s disease, the distribution and density of cannabinoid CB1, dopamine D1 and D2, adenosine A2a and GABAA receptor changes…
CHRI aims to inform clinical decision-making, product development and public policy related to the therapeutic use of cannabinoids.